Jill & Alex (GA)
Member Since 2009
A minor change for Lantus and Levemir users who are following the TR Protocol (as presented in this group) who are also using a pet meter (e.g. AlphaTrak, current version):
"If a serum chemistry analyzer or plasma-equivalent meter calibrated for cats is used (eg, AlphaTRAK from Abbott Animal Health), increase the target blood glucose concentration by about 1 mmol/L, 18 mg/dL, or adapt the normal range reported for cats as the target nadir glucose concentration (eg, change 2.8 to 3.8 mmol/L; change 50 to 68mg/dL)."
Please note: the current maker of the AlphaTrak is now Zoetis, not Abbott Animal Health.
Found at the bottom of Table 3: Dosing protocol for glargine or detemir and intensive blood glucose monitoring with a minimum of 3 blood glucose measurements per day (average5) using whole-blood human glucometers. ~ (Page 7 of the document or Page 257 of the publication)
What that means to you: Lantus and Levemir users following the TR Protocol and using a pet meter should take a dose reduction when kitty falls below 68 mg/dL or 3.8 mmol/L.
NOTE: The change above is for those following the TR Protocol only.
If you are a Lantus or Levemir user, and are using a pet meter, but you do NOT follow the TR Protocol, please see Table 2: Dosing protocol on glargine or detemir and glucose monitoring every 1 to 2 weeks using whole-blood human glucometers.
"If a serum chemistry analyzer or plasma-equivalent meter calibrated for cats is used (eg, AlphaTRAK from Abbott Animal Health), increase the target blood glucose concentration by about 1 mmol/L, 18mg/dL, or adapt the normal range reported for cats as the target nadir glucose concentration (eg, change 3–4 to 4–5mmol/L, change 54–72 to 72–90 mg/dL)."
(Found at the bottom of Table 2. Page 3 of the document or Page 253 of the publication.)
Please note: the current maker of the AlphaTrak is now Zoetis, not Abbott Animal Health.
"If a serum chemistry analyzer or plasma-equivalent meter calibrated for cats is used (eg, AlphaTRAK from Abbott Animal Health), increase the target blood glucose concentration by about 1 mmol/L, 18 mg/dL, or adapt the normal range reported for cats as the target nadir glucose concentration (eg, change 2.8 to 3.8 mmol/L; change 50 to 68mg/dL)."
Please note: the current maker of the AlphaTrak is now Zoetis, not Abbott Animal Health.
Found at the bottom of Table 3: Dosing protocol for glargine or detemir and intensive blood glucose monitoring with a minimum of 3 blood glucose measurements per day (average5) using whole-blood human glucometers. ~ (Page 7 of the document or Page 257 of the publication)
What that means to you: Lantus and Levemir users following the TR Protocol and using a pet meter should take a dose reduction when kitty falls below 68 mg/dL or 3.8 mmol/L.
NOTE: The change above is for those following the TR Protocol only.
If you are a Lantus or Levemir user, and are using a pet meter, but you do NOT follow the TR Protocol, please see Table 2: Dosing protocol on glargine or detemir and glucose monitoring every 1 to 2 weeks using whole-blood human glucometers.
"If a serum chemistry analyzer or plasma-equivalent meter calibrated for cats is used (eg, AlphaTRAK from Abbott Animal Health), increase the target blood glucose concentration by about 1 mmol/L, 18mg/dL, or adapt the normal range reported for cats as the target nadir glucose concentration (eg, change 3–4 to 4–5mmol/L, change 54–72 to 72–90 mg/dL)."
(Found at the bottom of Table 2. Page 3 of the document or Page 253 of the publication.)
Please note: the current maker of the AlphaTrak is now Zoetis, not Abbott Animal Health.
Last edited by a moderator:
